With the rapid development of China's economy and the rapid increase in the level of foreign trade, in the past ten years Techdow continuous to improve the management capacity and production capacity, improve product quality, efforts to expand the domestic market. At the same time Techdow speed up the international layout, and firmly implement the established strategy, take the international road, to put our products into the international market rapidly, and strive to achieve breakthrough in the international business development. Techdow’s Enoxaparin Sodium API and PFS have been sold in more than 50 countries around the world, and the number of countries is still increasing. Now, our company has become a leader in the global low molecular weight heparin industry. Our high quality enoxaparin sodium API has been recognized by all customers. Our enoxaparin sodium PFS obtained the EU marketing authorization with Brand name Inhixa, Neoparin. Techdow became the first Generic enoxaparin sodium injection supplier in EU market. The sales volume and sales of our Enoxaparin sodium API and PFS products accounted for nearly 50% of national exports, export sales and export volume accounted for the first national ranking.

 Techdow’s high-quality products has sold in countries and regions include: the United States, Britain, Poland, Germany, Italy, Morocco, Australia, South Korea, Thailand, Vietnam,  Bangladesh, the Philippines, Malaysia Laxia, Singapore, Indonesia and so on. Relying on the superior R&D strength, strong product line, competitive advantage of high quality products and professional product marketing team and extensive marketing network, Techdow will be into a new stage of rapid development in the international market.